CDS (n = 334) | Usual care (n = 301) | ||||
---|---|---|---|---|---|
n | (%) | n | (%) | P-value | |
Number of patients who reported at least one ER visit | 45 | (13.5) | 42 | (14.0) | 0.934 |
Number of ER visits | |||||
Mean (SD) | 0.3 | (1.0) | 0.4 | (1.8) | 0.536 |
Median (Q1, Q3) | 0.0 | (0.0, 0.0) | 0.0 | (0.0, 0.0) | |
Number of patients who reported at least one hospitalization | 22 | (6.6) | 21 | (7.0) | 0.763 |
Number of times admitted to hospital | |||||
Mean (SD) | 0.1 | (0.4) | 0.1 | (0.3) | 0.799 |
Median (Q1, Q3) | 0.0 | (0.0, 0.0) | 0.0 | (0.0, 0.0) | |
Number of patients who reported at least one family physician visit | 91 | (27.2) | 101 | (33.6) | 0.212 |
Number of times visited family physician | |||||
Mean (SD) | 0.9 | (2.2) | 1.1 | (2.6) | 0.168 |
Median (Q1, Q3) | 0.0 | (0.0, 0.0) | 0.0 | (0.0, 0.0) | |
Number of patients who reported at least one specialist visit | 158 | (47.3) | 141 | (46.8) | 0.756 |
Type of specialist | |||||
AF clinic visit/Anticoagulation nurse | 9 | (2.7) | 7 | (2.3) | 0.816 |
Cardiologist | 121 | (36.2) | 105 | (34.9) | 0.792 |
Internal medicine | 43 | (12.9) | 48 | (15.9) | 0.476 |
Complementary Health | 6 | (1.8) | 1 | (0.3) | 0.265 |
Number of patients with at least one NOAC medication | 136 | (40.7) | 128 | (42.5) | 0.407 |
Number of patients with NOAC coverage | |||||
Nova Scotia Pharmacare | 41 | (30.1) | 38 | (29.7) | 0.894 |
Private Insurance | 68 | (50.0) | 68 | (53.1) | 0.494 |
Self | 27 | (19.9) | 18 | (14.8) | 0.390 |
Not documented | 0 | (0.0) | 4 | (2.3) | |
Number of patients who reported use of other medications | |||||
St John’s Wort | 2 | (0.7) | 1 | (0.3) | 0.632 |
Aspirin | 53 | (15.9) | 38 | (12.6) | 0.582 |
Voltaren | 29 | (8.7) | 24 | (8.0) | 0.643 |
Naproxen | 2 | (0.7) | 1 | (0.3) | 0.633 |
Ibuprofen | 6 | (1.8) | 4 | (1.3) | 0.650 |
Number of patients who reported work loss due to AF | 8 | (2.4) | 10 | (3.3) | 0.661 |
Number of patients who reported hiring a paid caregiver | 5 | (1.5) | 4 | (1.3) | 0.898 |